Clinical Trials Logo

Anxiety Disorders clinical trials

View clinical trials related to Anxiety Disorders.

Filter by:

NCT ID: NCT04111874 Completed - Clinical trials for Autism Spectrum Disorder

Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD

Start date: July 30, 2019
Phase: N/A
Study type: Interventional

This study implements an anxiety-focused, parent-led, therapist-assisted cognitive behavioral teletherapy for parents of youth with ASD and anxiety.

NCT ID: NCT04110379 Completed - Dental Anxiety Clinical Trials

Effect of Virtual Reality Glasses as a Distraction Method on Child's Anxiety During Dental Treatment

Start date: July 20, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate and compare the effect of virtual reality glasses (VR) to conventional behavior management techniques as a distraction method on child's dental anxiety during dental treatment

NCT ID: NCT04106713 Recruiting - Depression Clinical Trials

Understanding the Person, Exploring Change Across Psychotherapies

Xchange
Start date: October 4, 2019
Phase: N/A
Study type: Interventional

Identifying predictors and understanding mechanisms of change will inform referral to psychotherapy, triage and right-siting by helping clinicians to understand how their patients are likely to benefit from clinical interventions. This study will be the first of its kind conducted in an Asian hospital setting to identify the predictors of response to individual, group and internet-delivered CBT for the treatment of depressed and anxious patients in the Institute of Mental Health (IMH), Singapore. With increasing challenges with hospital workload, there is an increasing emphasis on group and online interventions. Understanding of the factors that may predict outcome from these therapies can improve right-siting by identifying who will get better without therapy or who may not benefit from a given form of therapy and guide personalisation of care. An important biological predictor of outcome is likely to be genetic risk as it has been demonstrated that patients with greater melancholia and a family history may not be sufficiently treated with brief courses of therapy. Identifying psychological factors underlying psychological distress and determining the extent to which these factors are addressed by these interventions will help to improve and individualise existing psychotherapy and motivate new psychotherapeutic interventions.

NCT ID: NCT04103723 Recruiting - Clinical trials for Preoperative Anxiety

Impact of Premedication on Anxiety

Impact
Start date: October 7, 2019
Phase:
Study type: Observational

IMPACT aims to evaluate the clinical routine practice of premedication in German hospitals and to estimate the influence of premedication on anxiety reduction.

NCT ID: NCT04097782 Completed - Stress Clinical Trials

Effects of Antenatal Education on Fear of Birth, Depression, Anxiety, Childbirth Self-efficacy, and Mode of Delivery in Primiparous Pregnant Women

Antenatal
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Background: Caesarean delivery rates are quite high, especially in primipara, in Turkey. Fear of birth, low childbirth self-efficacy, and psychological factors may be among the primary causes. Since antenatal educations are not universal and there are differences in educational contents, there is not sufficient evidence on this topic in international studies. Objective: To investigate the effects of antenatal education on birth fear, depression, anxiety, stress, childbirth self-efficacy, and mode of delivery in primiparous pregnant women.

NCT ID: NCT04093154 Completed - Pain Clinical Trials

Effect of VR on Pain, Fear and Anxiety During Accessing a Port With Huber Needle in Pediatric Cancer Patients

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

Virtual Reality (VR) can be used during needle-related procedures in children with cancer. The aim of this study was to investigate the effect of VR during access the venous port with Huber needle-related pain, fear and anxiety of children and adolescents with cancer.

NCT ID: NCT04091139 Completed - Anxiety Disorders Clinical Trials

Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong

Start date: September 24, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

The Unified Protocol (UP) is an emotion-focused, cognitive-behavioural intervention that is developed to target core temperamental characteristics underlying anxiety and depressive disorders. Ehrenreich and colleagues developed UP for adolescents (UP-A). The current study aims at evaluating efficacy of UP-A for the treatment of emotional disorders in Chinese adolescents in Hong Kong. The current study would recruit 27 Chinese-speaking patients, age 13 to 18, with a primary diagnosis of any Diagnostic and Statistical Manual (Fifth edition) anxiety disorders and/or depressive disorder. They would be randomized into one of the two treatment arms, namely UP-A treatment condition (UP-A), and treatment-as-usual (TAU) condition. Following randomization, participants in the UP-A condition would attend individual treatment based on UP-A, which last for 10 to 12 weeks. Participants in the TAU condition would be provided with usual clinical psychological service (i.e. treatment as usual) in the first 12 weeks before they start attending the same individual treatment program. Primary outcomes would be patient's self-rated measures on clinical symptoms, and secondary outcomes would be their clinical diagnoses, parent-rated and other self-rated measures. It is hypothesized that, comparing to those in TAU, participants in the UP-A condition would show improvements in depressive symptoms, anxiety symptoms and functional impairment at the end of treatment. When the outcomes of all participants are combined, it is hypothesized that participants will show demonstrate improvement in depressive symptoms, anxiety symptoms, and functional impairment after completing the UP-A and at the 3-month follow-up.

NCT ID: NCT04089085 Active, not recruiting - Childhood Asthma Clinical Trials

STRONGer Together: A Small Group Intervention for Children With Asthma and Anxiety/Depression

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

The proposed study is a one group pilot to assess the feasibility and acceptability of an 8-session intervention (STRONGer Together) for children between 8 - 12 years of age with asthma and anxiety/depressive symptoms.

NCT ID: NCT04087564 Completed - Healthy Clinical Trials

The Impact of Music on Nociceptive Processing

Start date: June 13, 2019
Phase: N/A
Study type: Interventional

The investigators are studying the ways that different music may change pain perception

NCT ID: NCT04086342 Withdrawn - Clinical trials for Social Anxiety Disorder

CHI-902 for Treatment of Social Anxiety Disorder

Start date: January 24, 2020
Phase: Phase 2
Study type: Interventional

No substantial clinical trials of Cannabidiol (CBD) in Social Anxiety Disorder (SAD) have yet been conducted. This randomized doubleblind, placebo-controlled trial of CBD in adults with SAD will evaluate the efficacy, tolerability and safety of CBD oil (CHI-902) in SAD. In addition, the effects of treatment with CHI-902 on the Endocannabinoid System (ECS) will be assessed by evaluating peripheral endocannabinoids (Arachidonoylethanolamide/Anandamide (AEA) and 2-Arachidonoyl glycerol (2-AG)) before and after treatment.